Dual vs Triple Anti-Thrombotic Therapy for Post-PCI Patients With Atrial Fibrillation

Published: 21 May 2020

Views:
101
Likes:
0

Overview

Full programme

Views:
101
Likes:
0

Overview

Learning Objectives

Discuss and debate the four major trials in the DOAC space for post PCI patients with atrial fibrillation in light of international guidelines
Review the differences in the study designs and aspirin cut-offs and the implications on the data
Discuss and analyse the role of aspirin in the treatment of anti-thrombotic post PCI for patients with Atrial Fibrillation and ACS
Analyse and debate the impact on patient care

This video series was funded by an unrestricted educational service from Boehringer Ingelheim.

Series overview

Part 1

Scope of the Problem and Key Challenges

1 session

Scope of the Problem and Key Challenges
Watch now

Part 2

Evolution of the Data – the Trials and the Differences

1 session

Evolution of the Data – the Trials and the Differences
Watch now

Part 3

Practical Implementation and Current Guidelines

1 session

Practical Implementation and Current Guidelines
Watch now

Faculty biographies

Jan Steffel
Jur ten Berg
Stefan H Hohnloser

Jan Steffel

Professor Jan Steffel is Vice Chairman and Professor of Cardiology at the University of Zurich, Switzerland where he is also Senior Consultant in Invasive Electrophysiology and Cardiac Devices. He is board certified in Internal Medicine and Cardiology and holds EHRA as well as IBHRE Certification in both Invasive Electrophysiology and Cardiac Devices. His primary research focus is in the field of anticoagulation for stroke prevention in atrial fibrillation as well as novel technologies in cardiac devices.

View full profile

Jur ten Berg

Prof Jur ten Berg is Head of the St Antonius Center for Platelet Function Studies at the St Antonius Hospital, The Netherlands, where he also serves as Director of the Cardiology Training Programme. He has published over 400 peer-reviewed articles.

View full profile

Stefan H Hohnloser

Professor of Medicine and Cardiology

Stefan H Hohnloser is Professor of Medicine and Cardiology at the Johann Wolfgang Goethe University in Frankfurt, Germany, where he is the Head of the Department of Electrophysiology. His primary research interests include sudden cardiac death and its prevention by device therapy.

View full profile